Shah, Nisha B.
Zuckerman, Autumn D. http://orcid.org/0000-0002-8376-0691
Hosteng, Katie R.
Fann, Jessica
DeClercq, Josh
Choi, Leena
Cherry, Laura
Schwartz, David A.
Horst, Sara
Article History
Received: 19 December 2022
Accepted: 26 August 2023
First Online: 19 September 2023
Declarations
:
: Dr. Sara Horst has been a consultant for Janssen, Takeda, Abbvie, and BMS. Dr. David Schwartz has been a consultant for Abbvie, Genetech, Gilead, Janssen, Pfizer, Takeda, Tigenix, and UCB. Dr. Schwartz has also received research grant support from UCB and is a data safety and monitoring board member for Tract. Dr. Nisha Shah received research grant support from Pfizer Inc. and AstraZeneca. Dr. Autumn Zuckerman receives research support from Pfizer Inc. and AstraZeneca. Dr. Jessica Fann has been a consultant for Abbvie.
: This research study was conducted retrospectively from data obtained for clinical purposes and approved by the Vanderbilt University Medical Center IRB.